Legionella: Difference between revisions
From IDWiki
Legionella
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
(linkified) |
||
Line 1: | Line 1: | ||
==Background== |
==Background== |
||
===Microbiology=== |
===Microbiology=== |
||
* Small, fastidious Gram-negative bacilli |
|||
*Small, fastidious [[Stain::Gram-negative]] [[Cell shape::bacillus]] |
|||
* Uses proteins rather than carbohydrates as an energy source |
|||
*Uses proteins rather than carbohydrates as an energy source |
|||
** Requires media enriched with L-cysteine |
|||
**Requires media enriched with L-cysteine |
|||
* ''L. pneumophila'' is an facultative intracellular parasite of a number of amoebae |
|||
*''L. pneumophila'' is an facultative intracellular parasite of a number of amoebae |
|||
* Close relative of ''Coxiella burnetti'' |
|||
*Close relative of ''[[Coxiella burnetti]]'' |
|||
* Also have a quiescent state that is "viable but not cultivable" |
|||
*Also have a quiescent state that is "viable but not cultivable" |
|||
====Species==== |
====Species==== |
||
* ''L. pneumophila'' serogroup 1: most common cause (70-80%) |
|||
*''L. pneumophila'' serogroup 1: most common cause (70-80%) |
|||
* ''L. micdadei'': sometimes referred to as the "Pittsburgh pneumonia agent" or ''Tatlockia micdadei'' |
|||
*''L. micdadei'': sometimes referred to as the "Pittsburgh pneumonia agent" or ''Tatlockia micdadei'' |
|||
* ''L. pneumophila'' serogroups 2-15 |
|||
* |
*''L. pneumophila'' serogroups 2-15 |
||
* |
*''L. dumoffi'' |
||
* |
*''L. longbeachae'' |
||
*''L. bozemanii'' |
|||
===Epidemiology=== |
===Epidemiology=== |
||
* Ubiquitous in water: lakes, streams, oceans |
|||
*Ubiquitous in water: lakes, streams, oceans |
|||
** Warm water has higher burden of bacteria |
|||
**Warm water has higher burden of bacteria |
|||
** Free-living water amoebae support intracellular growth of ''Legionella'' |
|||
**Free-living water amoebae support intracellular growth of ''Legionella'' |
|||
* No person-to-person transmission (one case report) |
|||
*No person-to-person transmission (one case report) |
|||
* Most cases are sporadic, but there are also epidemics |
|||
* |
*Most cases are sporadic, but there are also epidemics |
||
**Half of cases are associated with travel |
|||
** Other risk factors include cell-mediated immunocompromise (e.g. anti-TNF-alpha) |
|||
**Other risk factors include cell-mediated immunocompromise (e.g. anti-TNF-alpha) |
|||
** Also spas, hot tubs, potting mix |
|||
**Also spas, hot tubs, potting mix |
|||
* Most common strain is ''L. pneumophila'' Pontiac subtype serogroup 1 (90%) |
|||
*Most common strain is ''L. pneumophila'' Pontiac subtype serogroup 1 (90%) |
|||
===Pathophysiology=== |
===Pathophysiology=== |
||
* Inhalation or microaspiration |
|||
*Inhalation or microaspiration |
|||
* Phagocytosed by alveolar macrophages |
|||
*Phagocytosed by alveolar macrophages |
|||
** Replicate intracellularly, then escape and are rephagocytosed by other macrophages |
|||
**Replicate intracellularly, then escape and are rephagocytosed by other macrophages |
|||
* The population of bacteria increases in the lungs |
|||
*The population of bacteria increases in the lungs |
|||
** Infiltration by neutrophils etc causes pulmonary edema |
|||
**Infiltration by neutrophils etc causes pulmonary edema |
|||
==Clinical Manifestations== |
==Clinical Manifestations== |
||
* Incubation period of 2 to 10 days (median 4 to 6 days); at most 28 days |
|||
*Incubation period of 2 to 10 days (median 4 to 6 days); at most 28 days |
|||
===Legionnaires' disease=== |
===Legionnaires' disease=== |
||
* Presents as a community-acquired or healthcare-associated pneumonia |
|||
*Presents as a community-acquired or healthcare-associated pneumonia |
|||
* May have a prodrome of hours to days that involves headaches, myalgias, asthenia, and anorexia, possibly fevers |
|||
*May have a prodrome of hours to days that involves headaches, myalgias, asthenia, and anorexia, possibly fevers |
|||
** Diarrhea and abdominal pain |
|||
**Diarrhea and abdominal pain |
|||
** Cough, sometimes chest pain, sometimes productive |
|||
**Cough, sometimes chest pain, sometimes productive |
|||
* Fevers with pulse-temperature dissociation, myalgias, nonproductive cough, diarrhea, confusion, hyponatremia, hypophosphatemia, and elevated liver enzymes |
|||
*Fevers with pulse-temperature dissociation, myalgias, nonproductive cough, diarrhea, confusion, hyponatremia, hypophosphatemia, and elevated liver enzymes |
|||
* Can have leukopenia, thrombocytopenia, DIC, leukocytosis, pyuria |
|||
*Can have leukopenia, thrombocytopenia, DIC, leukocytosis, pyuria |
|||
===Extrapulmonary infections=== |
===Extrapulmonary infections=== |
||
* Rare, in immunocompromised patients or severe illness |
|||
*Rare, in immunocompromised patients or severe illness |
|||
** Except for pleural effusions, which are common |
|||
**Except for pleural effusions, which are common |
|||
* Can develop abscesses in brain, spleen, extrathoracic lymph nodes, and skeletal and myocardial myscles |
|||
*Can develop abscesses in brain, spleen, extrathoracic lymph nodes, and skeletal and myocardial myscles |
|||
* Case reports of endocarditis |
|||
*Case reports of endocarditis |
|||
===Pontiac fever=== |
===Pontiac fever=== |
||
* Incubation period 4 hours to 3 days |
|||
*Incubation period 4 hours to 3 days |
|||
* Self-limited, short febrile illness |
|||
*Self-limited, short febrile illness |
|||
** Fevers, myalgias, headaches, and asthenia |
|||
**Fevers, myalgias, headaches, and asthenia |
|||
** Only diagnosed when there's an outbreak, since they're usually not sick enough to present to healthcare |
|||
**Only diagnosed when there's an outbreak, since they're usually not sick enough to present to healthcare |
|||
** Outbreaks associated with industrial processes using sprayed water, recreational spas, decorative water fountains, and cooling towers |
|||
**Outbreaks associated with industrial processes using sprayed water, recreational spas, decorative water fountains, and cooling towers |
|||
* Can have cough, dyspnea, anorexia, arthralgia, and abdominal pain |
|||
*Can have cough, dyspnea, anorexia, arthralgia, and abdominal pain |
|||
==Diagnosis== |
==Diagnosis== |
||
* Legionella urine antigen if the most widely-used test |
|||
*Legionella urine antigen if the most widely-used test |
|||
** Most sensitive for ''L. pneumophila'' serogroup 1, less sensitive for others |
|||
**Most sensitive for ''L. pneumophila'' serogroup 1, less sensitive for others |
|||
* Cultured best on buffered charcoal yeast extract (BCYE) agar is preferred |
|||
*Cultured best on buffered charcoal yeast extract (BCYE) agar is preferred |
|||
** Colistin |
|||
**Colistin |
|||
** Needs cysteine |
|||
**Needs cysteine |
|||
* Stained best with Warthin-Starry or Dieterle, but stains poorly |
|||
*Stained best with Warthin-Starry or Dieterle, but stains poorly |
|||
{| class="wikitable" |
{| class="wikitable" |
||
! |
!Test |
||
! |
!Specimens |
||
! |
!Sensitivity |
||
! |
!Specificity |
||
! |
!Notes |
||
|- |
|- |
||
| |
|Culture |
||
| |
|Spurum, other lower respiratory tract secretions, lung, pleural fluid, blood, extrapulmonary tissues, fluids |
||
| |
|20-95% |
||
| |
|100% |
||
| |
|Positive several days after treatment, needs special media |
||
|- |
|- |
||
| |
|Antigen |
||
| |
|Urine |
||
| |
|60-95% |
||
| |
|>99% |
||
| |
|Highest sensitivity for serogroup 1, Pontiac type; positive for days to months |
||
|- |
|- |
||
| |
|Immunofluorescent microscopy |
||
| |
|Same as culture |
||
| |
|20-50% |
||
| |
|99% |
||
| |
|Highest specificity with monoclonal antibody |
||
|- |
|- |
||
| |
|Antibody |
||
| |
|Paired serum (acute and convalescent) |
||
| |
|20-70% |
||
| |
|95-99% |
||
| |
|Highest specificity for serogroup 1 |
||
|- |
|- |
||
| |
|Molecular amplification |
||
| |
|Sputum (ideally BAL), other lower respiratory tract secretions, urine |
||
| |
|70-95% |
||
| |
|90-95% |
||
| |
|Not well standardized, good performance in reference labs |
||
|} |
|} |
||
==Management== |
==Management== |
||
* First-line: Levofloxacin 750mg PO or IV once daily or Moxifloxacin 400mg PO or IV once daily |
|||
*First-line: [[Is treated by::Levofloxacin]] 750mg PO or IV once daily or [[Is treated by::moxifloxacin]] 400mg PO or IV once daily |
|||
* Alternative: Azithromycin 500mg PO or IV once daily |
|||
*Alternative: [[Is treated by::azithromycin]] 500mg PO or IV once daily |
|||
* Usual duration 7-10 days |
|||
*Usual duration 7-10 days |
|||
* No need to treat Pontiac fever |
|||
*No need to treat Pontiac fever |
|||
==Prevention== |
==Prevention== |
||
* [https://www.cdc.gov/legionella/health-depts/index.html https://www.cdc.gov/legionella/health-depts/index.html] |
|||
*https://www.cdc.gov/legionella/health-depts/index.html |
|||
{{DISPLAYTITLE:''Legionella'' species}} |
{{DISPLAYTITLE:''Legionella'' species}} |
Revision as of 10:55, 2 August 2020
Background
Microbiology
- Small, fastidious Gram-negative bacillus
- Uses proteins rather than carbohydrates as an energy source
- Requires media enriched with L-cysteine
- L. pneumophila is an facultative intracellular parasite of a number of amoebae
- Close relative of Coxiella burnetti
- Also have a quiescent state that is "viable but not cultivable"
Species
- L. pneumophila serogroup 1: most common cause (70-80%)
- L. micdadei: sometimes referred to as the "Pittsburgh pneumonia agent" or Tatlockia micdadei
- L. pneumophila serogroups 2-15
- L. dumoffi
- L. longbeachae
- L. bozemanii
Epidemiology
- Ubiquitous in water: lakes, streams, oceans
- Warm water has higher burden of bacteria
- Free-living water amoebae support intracellular growth of Legionella
- No person-to-person transmission (one case report)
- Most cases are sporadic, but there are also epidemics
- Half of cases are associated with travel
- Other risk factors include cell-mediated immunocompromise (e.g. anti-TNF-alpha)
- Also spas, hot tubs, potting mix
- Most common strain is L. pneumophila Pontiac subtype serogroup 1 (90%)
Pathophysiology
- Inhalation or microaspiration
- Phagocytosed by alveolar macrophages
- Replicate intracellularly, then escape and are rephagocytosed by other macrophages
- The population of bacteria increases in the lungs
- Infiltration by neutrophils etc causes pulmonary edema
Clinical Manifestations
- Incubation period of 2 to 10 days (median 4 to 6 days); at most 28 days
Legionnaires' disease
- Presents as a community-acquired or healthcare-associated pneumonia
- May have a prodrome of hours to days that involves headaches, myalgias, asthenia, and anorexia, possibly fevers
- Diarrhea and abdominal pain
- Cough, sometimes chest pain, sometimes productive
- Fevers with pulse-temperature dissociation, myalgias, nonproductive cough, diarrhea, confusion, hyponatremia, hypophosphatemia, and elevated liver enzymes
- Can have leukopenia, thrombocytopenia, DIC, leukocytosis, pyuria
Extrapulmonary infections
- Rare, in immunocompromised patients or severe illness
- Except for pleural effusions, which are common
- Can develop abscesses in brain, spleen, extrathoracic lymph nodes, and skeletal and myocardial myscles
- Case reports of endocarditis
Pontiac fever
- Incubation period 4 hours to 3 days
- Self-limited, short febrile illness
- Fevers, myalgias, headaches, and asthenia
- Only diagnosed when there's an outbreak, since they're usually not sick enough to present to healthcare
- Outbreaks associated with industrial processes using sprayed water, recreational spas, decorative water fountains, and cooling towers
- Can have cough, dyspnea, anorexia, arthralgia, and abdominal pain
Diagnosis
- Legionella urine antigen if the most widely-used test
- Most sensitive for L. pneumophila serogroup 1, less sensitive for others
- Cultured best on buffered charcoal yeast extract (BCYE) agar is preferred
- Colistin
- Needs cysteine
- Stained best with Warthin-Starry or Dieterle, but stains poorly
Test | Specimens | Sensitivity | Specificity | Notes |
---|---|---|---|---|
Culture | Spurum, other lower respiratory tract secretions, lung, pleural fluid, blood, extrapulmonary tissues, fluids | 20-95% | 100% | Positive several days after treatment, needs special media |
Antigen | Urine | 60-95% | >99% | Highest sensitivity for serogroup 1, Pontiac type; positive for days to months |
Immunofluorescent microscopy | Same as culture | 20-50% | 99% | Highest specificity with monoclonal antibody |
Antibody | Paired serum (acute and convalescent) | 20-70% | 95-99% | Highest specificity for serogroup 1 |
Molecular amplification | Sputum (ideally BAL), other lower respiratory tract secretions, urine | 70-95% | 90-95% | Not well standardized, good performance in reference labs |
Management
- First-line: Levofloxacin 750mg PO or IV once daily or moxifloxacin 400mg PO or IV once daily
- Alternative: azithromycin 500mg PO or IV once daily
- Usual duration 7-10 days
- No need to treat Pontiac fever